Stock Scorecard
Stock Summary for Inari Medical Inc (NARI) - $38.07 as of 4/26/2024 3:32:14 PM EST
Total Score
10 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NARI
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NARI
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NARI
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for NARI
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for NARI
Financial Details for NARI
Company Overview |
|
---|---|
Ticker | NARI |
Company Name | Inari Medical Inc |
Country | USA |
Description | Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients with venous disease in the United States. The company is headquartered in Irvine, California. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 4/30/2024 |
Stock Price History |
|
Last Day Price | 38.07 |
Last Day Price Updated | 4/26/2024 3:32:14 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 1,482,142 |
52-Week High | 71.85 |
52-Week Low | 36.73 |
Last Price to 52 Week Low | 3.65% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 48.42 |
Sector PE | 56.64 |
5-Year Average PE | -395.91 |
Free Cash Flow Ratio | 19.13 |
Industry Free Cash Flow Ratio | 60.10 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 3.09 |
Total Cash Per Share | 1.99 |
Book Value Per Share Most Recent Quarter | 8.05 |
Price to Book Ratio | 5.08 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 4.79 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 57,961,000 |
Market Capitalization | 2,206,575,270 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -83.90% |
Annual Earnings Growth | 94.41% |
Reported EPS 12 Trailing Months | -0.03 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -0.03 |
Net Income Twelve Trailing Months | -1,636,000 |
Net Income Past Year | -1,636,000 |
Net Income Prior Year | -29,267,000 |
Quarterly Revenue Growth YOY | 22.60% |
5-Year Revenue Growth | 52.30% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 115,452,000 |
Total Cash Past Year | 115,452,000 |
Total Cash Prior Year | 326,401,000 |
Net Cash Position Most Recent Quarter | 115,835,000 |
Net Cash Position Past Year | 115,835,000 |
Long Term Debt Past Year | -383,000 |
Long Term Debt Prior Year | 19,481,000 |
Total Debt Most Recent Quarter | -383,000 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 464,910,000 |
Total Stockholder Equity Prior Year | 417,002,000 |
Total Stockholder Equity Most Recent Quarter | 464,910,000 |
Options |
|
Put/Call Ratio | 0.12 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -2.33 |
MACD Signal | -2.12 |
20-Day Bollinger Lower Band | 33.12 |
20-Day Bollinger Middle Band | 52.21 |
20-Day Bollinger Upper Band | 71.29 |
Beta | 0.84 |
RSI | 29.74 |
50-Day SMA | 57.81 |
200-Day SMA | 72.84 |
System |
|
Modified | 4/27/2024 6:34:30 AM EST |